Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 18/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL6994186 | 1.00 | HRH3 (0.58) | HRH3MEN1KMT2A | |
| Oxalic Acid SCHEMBL6993011 | 0.91 | HRH3 (0.48) | HRH3KMT2A | |
| Oxalic Acid SCHEMBL6995605 | 0.91 | HRH3 (0.48) | HRH3KMT2A | |
| Oxalic Acid SCHEMBL6987195 | 0.90 | RAB9A (0.53) | HRH3KMT2A | |
| Oxalic Acid SCHEMBL6997995 | 0.90 | RAB9A (0.53) | HRH3KMT2A | |
| Oxalic Acid SCHEMBL6992880 | 0.90 | KDM4E (0.53) | HRH3MEN1KMT2A | |
| Oxalic Acid SCHEMBL7087968 | 0.90 | KDM4E (0.53) | HRH3MEN1KMT2A | |
| Oxalic Acid SCHEMBL6997680 | 0.90 | KDM4E (0.53) | HRH3MEN1KMT2A | |
| Oxalic Acid SCHEMBL7087974 | 0.90 | KDM4E (0.53) | HRH3MEN1KMT2A | |
| Oxalic Acid SCHEMBL6997413 | 0.90 | HRH3 (0.61) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0853615-B1 | PIPERIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS | NEUROSEARCH AS (DK) | 2003-12-10 | — | — | EP | disclosed |
| US-5981539-A | TREATMENT OF STROKE, ANOXIA, ISCHEMIA, MIGRAINE, PSYCHOSIS, EPILEPSY OR ANY OTHER CONVULSIVE DISORDER | NEUROSEARCH A/S (DK) | 1999-11-09 | — | — | US | disclosed |